ChenGuang Biotech Group Co., Ltd. (300138.SZ)
CNY 8.97
(-0.44%)
CNY 8.97
(-0.44%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 6.87 Billion | 6.29 Billion | 4.87 Billion | 3.91 Billion | 3.26 Billion | 3.06 Billion |
| Cost of Revenue | 6.11 Billion | 5.41 Billion | 4.15 Billion | 3.26 Billion | 2.68 Billion | 2.62 Billion |
| Gross Profit | 755.91 Million | 877.72 Million | 719.08 Million | 652.01 Million | 581.31 Million | 437.77 Million |
| Operating Expenses | 249.59 Million | 370.51 Million | 290.43 Million | 254.29 Million | 318.81 Million | 248.09 Million |
| Selling, General and Administrative Expenses | 74.29 Million | 100.74 Million | 91.17 Million | 85.32 Million | 189.56 Million | 144.72 Million |
| Research and Development Expenses | 91.89 Million | 129.02 Million | 94.79 Million | 82.58 Million | 49.2 Million | 29.34 Million |
| Other Expenses | 13.42 Million | 14.74 Million | 13.19 Million | 1.56 Million | 7.46 Million | 9.33 Million |
| Cost and Expenses | 6.32 Billion | 5.78 Billion | 4.44 Billion | 3.51 Billion | 3 Billion | 2.87 Billion |
| Operating Income | 548.32 Million | 487.01 Million | 384.86 Million | 311.05 Million | 203.1 Million | 141.19 Million |
| Interest Expense | 83.5 Million | 67.2 Million | 53.14 Million | 78.07 Million | 65.52 Million | 46.07 Million |
| Income Tax Expense | 61.64 Million | 65.67 Million | 47.46 Million | 46.48 Million | 20.7 Million | 8.55 Million |
| Earnings before Tax | 542.69 Million | 501.75 Million | 398.06 Million | 312.62 Million | 210.56 Million | 150.97 Million |
| Net Income | 479.72 Million | 434.03 Million | 351.51 Million | 267.74 Million | 193.57 Million | 145.28 Million |
| Earnings Per Share Basic | 0.90 | 0.81 | 0.67 | 0.55 | 0.38 | 0.28 |
| Earnings Per Share Diluted | 0.90 | 0.81 | 0.67 | 0.53 | 0.38 | 0.28 |
| Weighted Average Shares Outstanding | 532.01 Million | 532.75 Million | 528.51 Million | 483.28 Million | 513.59 Million | 512.82 Million |
| Weighted Average Shares Outstanding (Diluted) | 532.01 Million | 532.75 Million | 528.51 Million | 507.56 Million | 513.59 Million | 512.82 Million |
| Gross Margin | 0.11 | 0.14 | 0.15 | 0.17 | 0.18 | 0.14 |
| EBIT Margin | 0.11 | 0.12 | 0.12 | 0.14 | 0.11 | 0.09 |
| Profit Margin | 0.07 | 0.07 | 0.07 | 0.07 | 0.06 | 0.05 |
| EBITDA | 781.12 Million | 689.32 Million | 564.84 Million | 502.98 Million | 364.88 Million | 273.35 Million |
| Earnings Before Tax Margin | 0.08 | 0.08 | 0.08 | 0.08 | 0.06 | 0.05 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 1.73 Billion | 1.75 Billion | 1.72 Billion | 6.85 Billion | 1.69 Billion | 1.5 Billion |
| Cost of Revenue | 1.63 Billion | 1.62 Billion | 1.59 Billion | 6.11 Billion | 1.54 Billion | 1.3 Billion |
| Gross Profit | 96.25 Million | 129.42 Million | 138.29 Million | 739.14 Million | 150.72 Million | 200.26 Million |
| Operating Expenses | 53.06 Million | 70.01 Million | 74.04 Million | 258.78 Million | 89.04 Million | 74.39 Million |
| Selling, General and Administrative Expenses | 80.19 Million | 46.87 Million | 48.46 Million | - | 45.74 Million | 115.55 Million |
| Research and Development Expenses | 24.52 Million | 23.2 Million | 23.14 Million | - | 34.97 Million | 22.71 Million |
| Other Expenses | -51.65 Million | 60.6 Thousand | -2.43 Million | 13.42 Million | -8.32 Million | 12.34 Million |
| Cost and Expenses | 1.69 Billion | 1.69 Billion | 1.66 Billion | 6.37 Billion | 1.63 Billion | 1.37 Billion |
| Operating Income | -47.55 Million | 59.4 Million | 64.25 Million | 480.35 Million | 61.68 Million | 110.84 Million |
| Interest Expense | 18.68 Million | 33.38 Million | 31.75 Million | 83.5 Million | 22.55 Million | 18.81 Million |
| Income Tax Expense | 8.8 Million | 9.04 Million | 11.26 Million | 61.64 Million | 6.6 Million | 13.34 Million |
| Earnings before Tax | -39.74 Million | 69.25 Million | 33.44 Million | 542.69 Million | 81.6 Million | 114.56 Million |
| Net Income | -37.22 Million | 61.24 Million | 38.59 Million | 479.72 Million | 81.36 Million | 99.7 Million |
| Earnings Per Share Basic | -0.08 | 0.12 | 0.08 | - | 0.15 | 0.19 |
| Earnings Per Share Diluted | -0.08 | 0.12 | 0.08 | - | 0.15 | 0.19 |
| Weighted Average Shares Outstanding | 495.67 Million | 495.67 Million | 512.6 Million | 532.01 Million | 528.35 Million | 532.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 495.67 Million | 495.67 Million | 512.6 Million | 532.01 Million | 528.35 Million | 532.77 Million |
| Gross Margin | 0.06 | 0.07 | 0.08 | 0.11 | 0.09 | 0.13 |
| EBIT Margin | -0.01 | 0.06 | 0.07 | - | 0.06 | 0.10 |
| Profit Margin | -0.02 | 0.03 | 0.02 | 0.07 | 0.05 | 0.07 |
| EBITDA | -21.05 Million | 102.79 Million | 117.46 Million | - | 105.3 Million | 151.55 Million |
| Earnings Before Tax Margin | -0.03 | 0.03 | 0.04 | 0.07 | 0.04 | 0.07 |
ELIS
6771
PVGDF
ODET
HHI
NEXXY